Levels to watch: FTSE, DAX and S&P 500

A good start for the FTSE 100 has not been matched by the DAX, which is struggling to establish a clear direction.

Trader watching data screens
Source: Bloomberg

FTSE 100 rally continues

There seems to be little sign of the FTSE running out of steam at present, especially as US markets remain resilient ahead of Thanksgiving. Upside targets are now 6902, the 50-day simple moving average (SMA), and then 7000 (the election night peak), followed by 7070.

A return to the rising hourly trendline towards 6790 could be where buyers step in if we see additional weakness.

FTSE 100 price chart

DAX buying stalls

So far there’s no signal of real buying momentum, with the index needing to break yesterday’s highs at 10,780 and then get above the vital 10,800 line. A turn lower still targets 10,572, the 50-day SMA. 

DAX price chart

S&P 500 breaches all-time highs

New all-time highs here confirm the pre-Thanksgiving short squeeze is not letting up. The 50-hour SMA (2198) is still providing good support. It will take a close below 2190 to suggest a downward move is beginning.  

S&P 500 price chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.